Preliminary probiotic and technological characterization of Pediococcus pentosaceus strain KID7 and in vivo assessment of its cholesterol-lowering activity by Karthiyaini Damodharan et al.
ORIGINAL RESEARCH
published: 04 August 2015
doi: 10.3389/fmicb.2015.00768
Frontiers in Microbiology | www.frontiersin.org 1 August 2015 | Volume 6 | Article 768
Edited by:
Fabio Minervini,
Università degli Studi di Bari Aldo
Moro, Italy
Reviewed by:
Baltasar Mayo,
Consejo Superior de Investigaciones
Científicas, Spain
Rasu Jayabalan,
National Institute of Technology,
Rourkela, India
Fatemeh Nejati,
Islamic Azad University, Iran
*Correspondence:
Seung Hwan Yang,
Graduate School of Interdisciplinary
Program of Biomodulation, College of
Natural Science, Center for
Nutraceutical and Pharmaceutical
Materials, Myongji University (Science
Campus), Cheoin-gu, Yongin,
Gyeonggi-do 449-728, South Korea
ymichigan@mju.ac.kr;
Joo-Won Suh,
Division of Bioscience and
Bioinformatics, College of Natural
Science, Center for Nutraceutical and
Pharmaceutical Materials, Myongji
University (Science Campus),
Cheoin-gu, Yongin, Gyeonggi-do
449-728, South Korea
jwsuh@mju.ac.kr
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Food Microbiology,
a section of the journal
Frontiers in Microbiology
Received: 09 April 2015
Accepted: 14 July 2015
Published: 04 August 2015
Citation:
Damodharan K, Lee YS, Palaniyandi
SA, Yang SH and Suh J-W (2015)
Preliminary probiotic and technological
characterization of Pediococcus
pentosaceus strain KID7 and in vivo
assessment of its cholesterol-lowering
activity. Front. Microbiol. 6:768.
doi: 10.3389/fmicb.2015.00768
Preliminary probiotic and
technological characterization of
Pediococcus pentosaceus strain
KID7 and in vivo assessment of its
cholesterol-lowering activity
Karthiyaini Damodharan 1, 2 †, Young Sil Lee 2†, Sasikumar A. Palaniyandi 2, 3 †,
Seung Hwan Yang 2, 3* and Joo-Won Suh 1, 2*
1Division of Biosciences and Bioinformatics, Myongji University, Yongin, South Korea, 2Center for Nutraceutical and
Pharmaceutical Materials, Myongji University, Yongin, South Korea, 3Graduate School of Interdisciplinary Program of
Biomodulation, College of Natural Science, Myongji University, Yongin, South Korea
The study was aimed to characterize the probiotic properties of a Pediococcus
pentosaceus strain, KID7, by in vitro and in vivo studies. The strain possessed tolerance
to oro-gastrointestinal transit, adherence to the Caco-2 cell line, and antimicrobial
activity. KID7 exhibited bile salt hydrolase activity and cholesterol-lowering activity,
in vitro. In vivo cholesterol-lowering activity of KID7 was studied using atherogenic
diet-fed hypercholesterolemic mice. The experimental animals (C57BL/6J mice) were
divided into 4 groups viz., normal diet-fed group (NCD), atherogenic diet-fed group
(HCD), atherogenic diet- and KID7-fed group (HCD-KID7), and atherogenic diet- and
Lactobacillus acidophilus ATCC 43121-fed group (HCD-L.ac) as positive control. Serum
total cholesterol (T-CHO) level was significantly decreased by 19.8% in the HCD-KID7
group (P < 0.05), but not in the HCD-L.ac group compared with the HCD group.
LDL cholesterol levels in both HCD-KID7 and HCD-L.ac groups were decreased by
35.5 and 38.7%, respectively, compared with HCD group (both, P < 0.05). Glutamyl
pyruvic transaminase (GPT) level was significantly lower in the HCD-KID7 and HCD-L.ac
groups compared to HCD group and was equivalent to that of the NCD group. Liver
T-CHO levels in the HCD-KID7 group were reduced significantly compared with the
HCD group (P < 0.05) but not in the HCD-L.ac group. Analysis of expression of
genes associated with lipid metabolism in liver showed that low-density lipoprotein
receptor (LDLR), cholesterol-7α-hydroxylase (CYP7A1) and apolipoprotein E (APOE)
mRNA expression was significantly increase in the HCD-KID7 group compared to
the HCD group. Furthermore, KID7 exhibited desired viability under freeze-drying and
subsequent storage conditions with a combination of skim milk and galactomannan. P.
pentosaceus KID7 could be a potential probiotic strain, which can be used to develop
cholesterol-lowering functional food after appropriate human clinical trials.
Keywords: Pediococcus, probiotic, oro-gastrointestinal transit, cholesterol-lowering, bile salt hydrolase,
LDL-receptor, cholesterol 7α-hydroxylase, storage viability
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Introduction
High blood cholesterol (hypercholesterolemia) is a risk factor
for cardiovascular diseases, which remains one of the largest
causes of death worldwide (Ishimwe et al., 2015). It has been
shown that a 1% reduction in serum cholesterol is associated
with an estimated reduction of 2–3% in the risk of coronary
heart disease (CHD) (Ishimwe et al., 2015). Statin drugs are
predominantly prescribed for the reduction of serum cholesterol
level and in turn the risk of CHD. There is an increasing interest
in non-drug therapies for lowering serum cholesterol and the
risk of CHD due to several adverse side effects of statin drugs
reported in the literature and by patients (Sultan and Hynes,
2013). An alternative is probiotics with cholesterol-lowering
activity. Probiotics are defined as “live microorganisms that,
when administered in adequate amounts, confer a health benefit
on the host” (Hill et al., 2014). Recently, several studies have
shown that probiotics could be used as alternative supplements
to exert cholesterol-lowering effects in humans (Trautvetter
et al., 2012; Fuentes et al., 2013; Guardamagna et al., 2014).
Probiotics have been suggested to reduce cholesterol via various
mechanisms (Ishimwe et al., 2015). Available literature suggests
that probiotics with bile salt hydrolase (BSH) activity show
cholesterol-lowering activity in vivo (Kumar et al., 2011; Jones
et al., 2012, 2014; Pavlovic et al., 2012; Degirolamo et al., 2014).
Other mechanisms such as cholesterol adsorption to cell surface,
cholesterol assimilation into bacterial cell membrane (Liong and
Shah, 2005a) and co-precipitation with deconjugated bile acids
(Liong and Shah, 2005b) are also proposed/demonstrated in vitro
without evidence of their occurrence in vivo.
Several species and strains belonging to the orders
Lactobacillales and Bifidobacteriales are widely recognized,
approved and used as probiotics with some yeast and
Bacillus sp. as well. The beneficial effects of probiotics
include but are not limited to gastro-intestinal microbial
balance, suppression of pathogens, immunomodulatory
activity, hypocholesterolemic activity, and alleviation of certain
conditions such as diarrhea, allergy, lactose intolerance, irritable
bowel syndrome, inflammatory bowel disease (IBD), and
colon cancer (reviewed in Nagpal et al., 2012). However, a
single probiotic microbe cannot provide all of these beneficial
effects and efficacy and the activity of probiotic strains vary
considerably. For example, certain probiotic strains show efficacy
against antibiotic-associated diarrhea but there is less evidence
for their efficacy against IBD.
Since, the probiotic property of microbes differs from one
strain to another, new strains must be assessed for their putative
probiotic properties according to FAO/WHO guidelines (FAO-
WHO, 2002). The FAO/WHO guideline recommends certain
testing methods to establish the health benefits of a microbe to
be called probiotic. The testing methods include in vitro and
in vivo study of oro-gastrointestinal transit tolerance, production
of antimicrobial substances, beneficial probiotic characters such
as cholesterol-lowering activity, anti-hypertensive activity, anti-
diabetic activity etc., and adherence to human intestinal cells,
before testing the microbe in human clinical trials (FAO-WHO,
2002). The guidelines also insist on the characterization of a
putative probiotic microbe for its safety that the strain should
not possess any transferrable antibiotic resistance (FAO-WHO,
2002). Additionally, any probiotic microbe should maintain its
viability and probiotic activity during industrial manufacturing
practices such as drying, and storage in various products.
The objective of this study was to establish the various
probiotic properties and cholesterol-lowering activity of a
Pediococcus pentosaceus strain KID7, through in vitro and in vivo
studies and technological characterization of strain KID7 for its
ability to maintain desired viability during manufacturing and
storage condition.
Materials and Methods
Microorganisms and Culture Conditions
Strain KID7 was isolated from fermented finger millet (Eleusine
coracana) gruel obtained from a household in Yongin, Korea.
The gruel was serial-10-fold diluted and 10−4 to 10−6 dilutions
were plated on de Man Rogosa and Sharpe (MRS) agar medium
and incubated at 37◦C for 24 h to pick as single colony of
strain KID7. The probiotic strains Lactobacillus rhamnosus
GG andLactobacillus acidophilus ATCC 43121 were obtained
from American Type Culture Collection (ATCC, Manassas, VA,
USA) and the type strain Pediococcus pentosaceus KACC 12311
was obtained from the Korean Agricultural Culture Collection
(KACC), Republic of Korea. The strains were cultured in MRS
agar medium and incubated at 37◦C for 24 h before being used
for experiments. The strains were stored as glycerol stocks (20%
glycerol in MRS broth) at −80◦C. The probiotic strains and type
strain P. pentosaceus KACC 12311 were used as reference strains
for comparison of probiotic and biochemical characteristics,
respectively.
Pathogenic microbes used in this study were obtained from
the Korean Collection for Type Cultures (KCTC), KACC and
Korean Culture Center of Microorganisms (KCCM), Republic of
Korea. The pathogenic strains were routinely cultured in Luria-
Bertani (LB) agar medium and stored as glycerol stocks (20%
glycerol in LB broth, v/v) at−80◦C.
Strain Identification and Biochemical Test
KID7 was identified by gram staining, microscopic examination
and the API 50 CHL kit (Biomerieux S.A., La Balme les
Grottes, France). In addition, the fermentation pattern of KID7
was identified using homo- and hetero-fermentation (HHD)
medium (Mcdonald et al., 1987). Enzyme activities such as β-
galactosidase, β-glucosidase and protease activity were studied
following previous reports (Vidhyasagar and Jeevaratnam, 2013;
Lee et al., 2014). KID7 was studied for its growth in the
presence of NaCl (1–10%, w/v) in MRS broth. Genomic DNA
of strain KID7 was isolated using a genomic DNA isolation kit
(GeneALL, Seoul, South Korea), following the manufacturer’s
protocol. PCR amplification of the 16S rRNA gene from KID7
was performed with the primers 27F and 1492R (Borges et al.,
2013) and sequencing of the PCR product was done with 27F
and 785F (5′-GGATTAGATACCCTGGTA-3′) primers to get a
partial sequence of the 16S rRNA gene. Sequencing service
was provided by Solgent Co. Ltd. (Seoul, South Korea). The
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sequence was searched for similarities in the EzTaxon database
using the BLAST program. A phylogenetic tree was constructed
using the closely related sequences by multiple alignment
using Clustal X followed by neighbor-joining phylogenetic
tree construction using MEGA 6 software (Tamura et al.,
2013).
In vitro Study of Probiotic Properties
Safety assessment
KID7 was subjected to safety assessment such as biogenic amine
production, hemolytic activity, and degradation of type III
mucin from porcine stomach (Sigma, St. Louis, MO, USA).
The biogenic amine production was tested according to the
procedure described by Bover-Cid and Holzapfel (1999) using
decarboxylase agar medium with or without amino acids
such as L-phenylalanine, L-lysine, L-tryptophan, L-tyrosine, L-
arginine, L-ornithine, or L-histidine. Hemolytic activity and
mucin degradation were tested by petri dish-based methods
described by Borges and Teixeira (2014) and Zhou et al. (2001),
respectively. The minimum inhibitory concentration (MIC) of
various antibiotics for strain KID7 was tested by 2-fold broth
microdilution method (Wiegand et al., 2008). Susceptibility of
the strain to a particular antibiotic was determined according to
the cut-off MIC values given by European Food Safety Authority
(EFSA, 2012).
Oro-gastrointestinal transit assay
Oro-gastrointestinal transit (OGT) tolerance assay was
performed according to the method described by Bove et al.
(2012) with modification. The assay mimic the physiological
conditions of oral, gastric and intestinal stress. The strain KID7
was subjected to oral stress for 10min in electrolyte solution
(sodium chloride, 6.2 g; potassium chloride, 2.2 g; calcium
chloride, 0.22 g; sodium bicarbonate, 1.2 g) (Marteau et al.,
1997) with 150 mg/L lysozyme (Sigma). This was followed by
gastric stress for a 30-min incubation in electrolyte solution of
pH 3 + 0.3% pepsin (Sigma) and another 30-min incubation
in electrolyte solution of pH 2 + 0.3% pepsin. Finally, the cells
were subjected to a 120-min incubation in intestinal electrolyte
solution (sodium chloride, 5 g; potassium chloride, 0.6 g; calcium
chloride, 0.25 g; pH 7) (Marteau et al., 1997) with 0.3% bile oxgall
(BD) and 0.1% pancreatin (Sigma-Aldrich). The strains in PBS
without stress were used as control. The cells were separated
from the stress solution after each stress by centrifugation
at 5000 rpm for 5min and either subjected to next stress or
used for viability analysis. The viability was calculated from
colony-forming units (cfu) of appropriate dilutions from the
control and stress-treated bacterial cells plated on MRS agar
medium incubated for 48 h at 37◦C. The bacterial viability at the
end of each stress was also monitored using the LIVE/DEAD
BacLight bacterial viability kit (Invitrogen, Oregon, USA)
following the manufacturer’s protocol. The live and dead bacteria
were visualized as green and red fluorescent cells, respectively
under a fluorescence microscope (Olympus BX50, Tokyo, Japan)
and photomicrographs were captured using a digital camera
(Olympus DP70, Tokyo, Japan).
Caco-2 cell culture and adhesion assay
Caco-2 cell line was obtained from KCTC (Korea) and routinely
cultured in minimum essential medium (MEM) high-glucose
medium (Gibco) supplemented with 20% (v/v) inactivated fetal
bovine serum and 100 U of antibiotics penicillin-streptomycin.
The culture was incubated at 37◦C with 5% CO2.For theadhesion
assay, the Caco-2 cell line was used between the 39th and 41st
passage, which phenotypically resembled the enterocytes and
expressed tight junction. The Caco-2 cells were seeded at the
concentration of 2 × 105 cfu/ml in 12-well cell culture plates
and incubated for 21 days to get polarized monolayer and 100%
confluence. The medium was changed every day.
The adhesion of lactic acid bacteria (LAB) strains to Caco-2
cells was determined by the method described by Lee et al. (2014)
with minor modification. Briefly, the Caco-2 cells were replaced
with non-antibiotic-supplementedMEMmedium 2 h prior to the
adhesion assay. 0.5ml of 18-h bacterial suspension in PBS was
mixed with an equal volume of non-antibiotic-supplemented cell
culture medium. The final concentration of bacteria was 1× 108
cfu/ml, added to each well of the tissue culture plate containing
the Caco-2 monolayer, and incubated at 37◦C in 5% CO2 for
2 h. After incubation, the number of adhered bacterial cells was
determined according to Lee et al. (2014).
Antimicrobial activity
The antimicrobial activity of strain KID7 was determined against
human, animal and food-borne pathogens listed in Table 2.
Strain KID7 was cultured in MRS broth for 48 h at 37◦C and
the culture filtrate was concentrated 10-fold by lyophilization.
One hundred microliter of concentrated crude culture filtrate
was loaded on to an 8-mm paper disc (ADVANTEC, Japan) and
dried. The disc was placed on the pathogen- spread LB agar
plate and incubated for 18 h and the zone of inhibition was
measured. The entire assay was performed in triplicates to check
the reproducibility. Hydrogen peroxide production by the LAB
strains was determined according to the method of Saito et al.
(2007).
Bile salt hydrolase activity
Bile salt hydrolase activity of KID7 was detected by thin-layer
chromatography (TLC). The reaction mixtures were prepared
by a method described by Guo et al. (2011) with slight
modification. MRS reaction mixture was prepared with 5mM
taurodeoxycholic acid (TDCA), or 5mMglycocholic acid (GCA),
or 5mM taurocholic acid (TCA) in sodium phosphate buffer
(pH 7.4). One milliliter of 18-h culture was mixed with an equal
volume of phosphate-buffered MRS + conjugated bile acid and
incubated for 36 h at 37◦C. After incubation, the mixture was
lyophilized, dissolved in 1ml of methanol and centrifuged to
remove precipitates. Three microliter of sample was spotted on
TLC (silica gel 60, 20 × 20 cm) and developed using a mobile
phase of hexane:methylethlyketone:glacial acetic acid (56:36:8,
v/v/v) (Chavez and Krone, 1976). After development, the plates
were dried with hot air, sprayed with 10% sulfuric acid in distilled
water, and heated at 110◦C for 10min in a hot air oven to detect
the free cholic acid, deoxycholic acid, and conjugated bile acids.
The spots were visualized under UV illumination.
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Determination of cholesterol-lowering activity
The LAB strains were studied for cholesterol-lowering activity
in MRS liquid broth supplied with cholesterol. MRS broth
was initially prepared with 0.05% cysteine-HCl to create
microaerophilic condition and autoclaved, followed by addition
of cholesterol (CHO) dissolved in ethanol:Tween 80 (3:1, v/v) to
a final concentration of 500µg/ml, w/v, in the MRS medium.
The ethanol concentration should not exceed 5%. The MRS-
CHO broth was inoculated with log phase bacterial culture (2%
v/v of A600 = 0.5 OD culture) and incubated at 37
◦C37◦C for
24 h. After the incubation, bacterial cells were pelleted out by
centrifugation at 1500× g at 4◦C4◦C for 10min. The cholesterol
concentration in spent medium was estimated by enzymatic
method using the BCS total cholesterol kit (Bioclinical System,
Seoul, South Korea) following the manufacturer’s protocol and
compared with uninoculatedMRS-CHO broth as control and the
percentage cholesterol removal was calculated. The cholesterol-
lowering activity of LAB was also studied in the presence of
0.3 and 0.5% bile. Additionally, growth of the LAB strains was
also measured in MRS-CHO, and MRS-CHO-bile (0.3 and 0.5%)
broth.
In vivo Study of Cholesterol-Lowering Activity of KID7
Experimental animals
Male C57BL/6J mice (7–8 weeks-old) were purchased from
Orient Bio (Sung-Nam, South Korea). The mice were housed
under temperature (23 ± 3◦C) and humidity-controlled
conditions (40 ± 6%) with a 12-h light/dark cycle and were
given free access to water and food throughout the experiment.
After acclimatization, the mice were fed an atherogenic diet
(HCD, 40 kcal % fat, 1.25% cholesterol and 0.5% cholic acid,
Cat #101556; Research Diets, NJ, USA) for 4 weeks to induce
hypercholesterolemia before the oral administration of LAB. One
group was continued with a normal diet (NCD). After 4 weeks,
HCD-fedmice were assigned to one of the following three groups
for 4–5 weeks: HCD-control (Con); HCD administered with
3 × 108 cfu/ml of KID7 (HCD-KID7); or HCD administered
with 3 × 108 cfu/ml of L. acidophilus ATCC 43121 (HCD-
L.ac). KID7 and L. acidophilus ATCC 43121 were mixed with
distilled water and administered by oral gavage once daily for 32
days and the control NCD and HCD groups were administered
distilled water alone. The body weight was measured once per
week for 6 weeks. Food intake (g/mouse/day) was determined
by subtracting the remaining food weight from the initial food
weight of the previous feeding day, and dividing by the number of
mice housed in the cage. The experimental design was approved
by the Ethical Committee of the Myongji Bioeffeciency Research
Center inMyongji University (Yongin-Si, Gyeonggi-do, Republic
of Korea), and the mice were maintained in accordance with
standard guidelines.
Collection of tissues
At the end of the 32-days treatment period, the mice were
sacrificed by cervical dislocation, and the liver and white adipose
tissue (WAT) were excised immediately, rinsed, weighed, frozen
in liquid nitrogen, and stored at−80◦C until analysis.
Serum biochemical analysis
For biochemical analyses of serum, blood samples were collected
from tail vein at 16-h-fasted state. Serum was obtained from
the blood by centrifugation (3000 rpm, 10min, 4◦C) and was
stored at−80◦C until analysis. Serum total cholesterol (T-CHO),
triglyceride (TG), HDL-cholesterol, glucose, glutamyl oxaloacetic
transaminase (GOT) and glutamyl pyruvic transaminase (GPT)
levels were determined by using commercial assay kits (Asan
Pharm, Seoul, Korea). Low-density lipoprotein (LDL) cholesterol
was calculated using the Friedewald formula (Friedewald et al.,
1972).
Liver and fecal lipid contents
Lipids from the isolated liver and feces was extracted using the
Folch method (Folch et al., 1957). The extracted lipid fraction
was used to measure the T-CHO and TG levels using commercial
kit mentioned above. Fecal cholic acid content was measured
following the method of Kumar et al. (2011).
Total RNA isolation and gene expression analysis
Total RNA was extracted from liver using the RNeasy
mini kit (Qiagen Korea, Seoul, South Korea) according to
the manufacturer’s protocol. Total RNA (1µg) was reverse-
transcribed to cDNAwith the PrimeScript RT reagent kit (Takara,
Shiga, Japan). The mRNA expression levels of cholesterol
metabolisms-related genes were evaluated by real-time PCR
using iQTM SYBR Green Supermix and the real-time PCR
iQTM5 system (Bio-Rad Laboratories, Hercules, CA, USA).
Relative gene expression levels were calculated by the difference
in Ct value after normalization with β-actin (ACTB) and were
expressed as the fold-change relative to the HCD control group.
The primers used in the experiments are listed in Table 1.
Technological Characterization
Viability of strain KID7 under freeze-drying and storage
conditions
KID7 was grown in MRS broth at 37◦C for 30 h (late log-
phase culture) and the cells were harvested by centrifugation at
3000 × g for 15min at 4◦C. The cell pellet was washed and
resuspended in PBS (control) and additives to give a final cell
concentration of 1.8 × 109 cfu/ml. The additives used were
1% (w/v) skim milk, 1% (w/v) galactomannan (Sigma-Aldrich),
1% (w/v) wheat bran hydrolysate, 0.5% (w/v) skim milk +
0.5% (w/v) galactomannan, and 0.5% (w/v) galactomannan +
0.5% (w/v) wheat bran hydrolysate, prepared separately in sterile
distilled water. Wheat bran hydrolysate was prepared following
the method of Wang et al. (2009). The cell suspension in PBS
and additives were frozen at −80◦C. The frozen suspensions
were subjected to freeze-drying using a lab-scale freeze dryer
(IlShin lab Co., ltd, Korea), pre-cooled to −80◦C. The samples
were dried under reduced pressure (5 mbar) for 24 h. The
freeze-dried samples were rehydrated using sterile distilled water
and serially diluted and plated on MRS agar to determine
the viable count. Alternatively, the freeze-dried samples were
stored at three different temperature viz., −20, 4, and 25◦C
for up to 6 months. The viable cell count present in each
sample was determined as described above. The number of
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TABLE 1 | The primer sequences used for quantitative real-time PCR.
Gene name Forward (5′ → 3′) Reverse (5′ → 3′) Reference
SREBF2 GGCCTCTCCTTTAACCCCTT CACCATTTACCAGCCACAGG Ahn et al., 2013
LDLR GCGTATCTGTGGCTGACACC TGTCCACACCATTCAAACCC
HMGCR GGGACCAACCTTCTACCTC GCCATCACAGTGCCACATA Wang et al., 2014
CYP7A1 TCTCAACGATACACTCTCCACC CTTCAGAGGCTGCTTTCATTGC
APOE GAACCGCTTCTGGGATTACCT TCAGTGCCGTCAGTTCTTGTG Ding et al., 2012
ACTB TGTCCACCTTCCAGCAGATGT AGCTCAGTAACAGTCCGCCTAGA
ACTB, β-actin; SREBF2, sterol regulatory element binding protein 2; HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase; LDLR, Low-density lipoprotein receptor; CYP7A1, cytochrome
P450 family 7 subfamily A polypeptide 1 (cholesterol 7 α-hydroxylase); APOE, apolipoprotein E.
colonies on MRS agar was calculated and the total cfu was
calculated for each sample stored at various temperatures and
time points.
Statistical analysis
Data are expressed as means ± SEM. The differences among
treatment groups were analyzed by One-Way ANOVA, followed
by Duncan test, using Origin 7 Software (MicroCal Software,
Northampton, MA, USA). Values of P < 0.05 were considered
to indicate statistical significance.
Results
Identification of Strain KID7 Based on 16S rDNA
Sequence and Biochemical Test
BLAST search of the EzTaxon database showed that the
16S rDNA sequence of KID7 (Genbank accession number
KJ810576) (1508 bp) showed 99.3% (difference of 10/1499 bp)
similarity with P. pentosaceus type strain DSM 20336. All other
Pediococcus species showed less than 98.5%, which is the cut-
off value for species-level comparison studies (Stackebrandt,
2011). Phylogenetic analysis of the 16S rRNA gene sequence
of KID7 with that of various Pediococcus species confirmed
its close relatedness to P. pentosaceus DSM 20336 (Figure S1).
Hence, P. pentosaceus KACC 12311 (=DSM 20336) was used
for comparative biochemical test with KID7. The biochemical
tests of strain KID7 and the closely related strain P. pentosaceus
KACC 12311 are shown in Table S1. The strain KID7 possess
various enzymatic activities such as protease, β-galactosidase
and β-glucosidase similar to that of P. pentosaceus KACC
12311. It showed difference in the carbohydrate utilization
pattern, which is considered as strain-level difference between
KID7 and P. pentosaceus KACC 12311. Strain KID7 grew
well in the presence of NaCl, however, a reduction in cell
growth was observed with increasing concentration of NaCl
(Figure S2).
In vitro Probiotic Properties of KID7
In vitro safety assessment of KID7
Strain KID7 was negative for hemolytic activity on blood agar
(Figure S3B), mucin degradation on mucin-supplied medium
(Figure S3C), and bioamine production on various amino acid-
supplied decarboxylase agar media (Figure S3A). The minimum
inhibitory concentration (MIC) of strain KID7 for selected
antibiotics was shown in Table 2. The strain KID7 was sensitive
to all antibiotics except kanamycin B sulfate and streptomycin
sulfate.
Survival of KID7 under simulated oro-gastrointestinal
transit condition
The strain KID7 showed good tolerance to oral, gastric and
intestinal stress based on the results of fluorescence microscopic
analysis for live and dead/damaged cells (Figure 1A) and plate
count obtained after each stress treatment (Figure 1B). We
observed a high amount of red fluorescent cells (indicating
dead/damaged cells) in the gastric stress (pH 2) and intestinal
stress in the fluorescence microscopic analysis (Figure 1A).
However, we observed that these were only damaged cells, as
they recovered during culture onMRS agar, which was evidenced
by the number of colony-forming units in the gastric stress and
intestinal stress (Figure 1B). Overall, a reduction of 1 log unit cfu
(P < 0.05) was observed at the end of the OGT assay compared
to the initial count (Figure 1B).
Adherence of KID7 to Caco-2 cell monolayer
The adherence of KID7, L. rhamnosus GG, and L. acidophilus
ATCC 43121 to Caco-2 cell monolayer was calculated as
the percentage of cells that remained attached to the Caco-2
monolayer after two washes compared to the initial amount
of LAB added (Figure 2). Plate count of the attached bacterial
cells revealed high adherence of KID7 cells (34.7%) (Figure 2)
compared to L. rhamnosus GG (14.2%) and L. acidophilus ATCC
43121 (5%) (Figure 2).
Antimicrobial activity of strain KID7
The concentrated culture filtrate from KID7 showed a broad-
spectrum antimicrobial activity against human, animal and food-
borne pathogens used in this study (Table 3). The antimicrobial
activity was observed against both gram-positive and gram-
negative pathogenic bacteria, whereas no antimicrobial activity
was observed against LAB strains tested. We observed that
KID7 (Figure S4A) and the reference strain P. pentosaceus
KACC 12311 (Figure S4B) did not produce H2O2, whereas,
L. rhamnosus GG produces H2O2, which is observed as a
zone of blue color around the colony on Prussian blue agar
(Figure S4C).
Bile salt hydrolase and cholesterol-lowering activity of
KID7
The strain KID7 possessed bile salt hydrolase activity that
deconjugated TDCA, GCA and TCA (Figure 3A). We
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FIGURE 1 | In vitro assessment of oro-gastrointestinal transit
tolerance of strain KID7 under simulated conditions. (A)
Fluorescence photomicrograph of KID7 cells after various stages of
simulated oro-gastrointestinal transit: (a) initial, (b) oral stress, (c) gastric
stress pH 3, (d) gastric stress pH 2, and (e) intestinal stress. The live,
and dead/damaged cells were identified by using the LIVE/DEAD
BacLight bacterial viability kit after oral, gastric and intestinal stress
treatment. Green color indicates viable bacteria; red color indicates
damaged or dead bacteria. (B) Viable count of KID7 after each stages
of simulated oro-gastrointestinal transit. The viable count of KID7 was
determined by plating the cells from each stage on MRS agar and
incubation at 37◦C for 48 h. Error bar represents standard error of
mean of three independent experiments. *** Significantly different from
initial count at P < 0.005.
FIGURE 2 | Adherence of P. pentosaceus strain KID7, L. rhamnosus
GG, and L. acidophilus ATCC 43121 to Caco-2 cell monolayer. The error
bars indicate standard deviation of three independent experiments.
observed a 40% decrease in in vitro cholesterol concentration
in MRS-CHO broth after the growth of KID7 for 24 h.
However, this reduction level was decreased in the presence
of bile oxgal—0.3% (33% cholesterol reduction) and—0.5%
(17% cholesterol reduction) (Figure 3B). The percentage of
cholesterol reduction by KID7 was comparatively higher
than that of P. pentosaceus KACC 12311 (Figure 3B). The
reduction in cholesterol-lowering activity of KID7 and P.
pentosaceus KACC 12311 in the presence of 0.3 and 0.5%
bile oxgal may be due to reduced cell growth in the presence
of bile compared to bile- non-supplied MRS-CHO broth
TABLE 2 | Antibiotic susceptibility of P. pentosaceus KID7.
Antibiotics Minimum inhibitory concentration EFSA cut-off
(MIC) (mg/L) (MIC) (mg/L)
Chloramphenicol 1 (S) 4
Tetracyclin hydrochloride 4 (S) 8
Erythromycin 0.25 (S) 1
Streptomycin sulfate 256 (R) 64
Gentamycin C 8 (S) 16
Clindamycin 0.5 (S) 1
Ampicillin 1 (S) 4
Kanamycin B sulfate 1024 (R) 64
Bacterial susceptibility to antibiotic was determined according to the cut-off values given
by EFSA (2012). S, Susceptible; R, Resistant.
(Figure 3C). These observations suggest that cell concentration
is the key factor that affects cholesterol reduction in liquid
broth.
In vivo Cholesterol-Lowering Activity of KID7
Effects of KID7 and L. acidophilus on body weight gain,
food intake, and organ weight
The body weight gain, food intake, and organweight are shown in
Table 4. Body weight gain was not significantly different among
all groups. Food intake of the NCD group was higher than that
of the HCD control group (P < 0.005), but there was no
significant difference in food intake among the HCD control and
HCD-LAB groups. WAT weight did not differ among all groups.
Liver weights in the NCD group were reduced vs. that of the
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TABLE 3 | Antimicrobial activity of culture filtrate of strain KID7.
Test strains Zone of inhibition (mm)*
GRAM POSITIVE PATHOGENS
Staphylococcus aureus KCCM 11335 15
Staphylococcus epidermidis KCTC
1917
12
Listeria monocytogenes KACC 10764 20
Staphylococcus aureus KCCM 40510
(Methicillin- resistant)
11
Bacillus cereus KACC 11240 10
GRAM NEGATIVE PATHOGENS
Salmonella typhi KCTC 2514 12
Salmonella choleraesuis KCTC 2932 15
Pseudomonas aeruginosa KCCM
11802
18
Yersinia enterocolitica ssp.
enterocolitica KACC 15320
20
Salmonella gallinarum KCTC 2931 26
Shigella boydii KACC 10792 14
Escherichia coli O138 KCTC 2615 11
E. coli O1 KCTC 2441 12
LACTIC ACID BACTERIA (GRAM POSITIVE)
Enterococcus durans KACC 10787 –
Lactobacillus fermentum KACC
11441
–
Lactobacillus plantarum ssp.
plantarum KACC 11451
–
Lactobacillus brevis KACC 11433 –
Lactobacillus paracasei KACC 12361 –
*Concentrated crude culture filtrate of strain KID7 was used for the antimicrobial assay. –,
Indicates no zone of inhibition.
HCD control group, but did not differ in the HCD control and
HCD-LAB groups.
Effects of KID7 and L. acidophilus on the serum
biochemical levels
As shown in Figure 4, T-CHO and LDL-CHO levels in the NCD
group were significantly lower compared to the HCD control
group (all, P < 0.005). T-CHO levels were significantly decreased
by 19.8% in the HCD-KID7 group (P < 0.05), but did not
in the HCD-L.ac group (Figure 4A). LDL-CHO levels in both
the HCD-KID7 and HCD-L.ac group were decreased by an
average of 35.5 and 38.7%, respectively, compared with the HCD
control group (both, P < 0.05) (Figure 4B). HDL-CHO and
TG level gain was not significantly different among all groups
(Figures 4C,D). GPT levels in the NCD, HCD-KID7, and HCD-
L.ac groups were reduced by 30, 30, and 28%, respectively, vs. the
HCD control group (all, P < 0.05) (Figure 4E). GOT levels in
the HCD-KID7 and HCD-L.ac groups showed the tendency to
reduce, but not statistically significant (Figure 4F).
Effects of KID7 and L. acidophilus on lipid content in
liver and feces
Liver T-CHO levels and TG in the NCD group were lower
than that of the HCD control group (P < 0.001 and P <
0.05, respectively) Figure 5. Liver T-CHO levels in the HCD-
KID7 group were reduced significantly compared with the HCD
control group (P < 0.05) (Figure 5A). Liver TG levels tended
to decrease in the HCD-KID7 group compared with the HCD
control group, but not statistically significant (Figure 5B). Fecal
T-CHO levels tended to increase in the HCD-KID7 group
compared with the HCD control group, but not statistically
significant (P = 0.056) (Figure 5C). A significant increase (P <
0.05) in fecal cholic acid content was observed in the HCD-
KID7 group compared to HCD group. In the HCD-L.ac group
no significant change in liver total cholesterol, liver triglyceride
content, fecal cholesterol and fecal cholic acid contents was noted
compared to the HCD control group (Figures 5A–D).
Effects of KID7 and L. acidophilus on expression levels of
genes associated with cholesterol metabolism in liver
We examined the expression levels of cholesterol metabolism-
related genes to understand the mechanism of action of
KID7 compared to L. acidophilus ATCC 43121 in improving
hypercholesterolemia (Figure 6). The NCD feeding was found to
significantly increase the SREBF2, HMGCR, LDLR, and APOE
gene expression levels compared to those of the HCD group.
SREBF2 gene expression level did not change in the HCD-
KID7 group, but significantly increased in the HCD-L.ac group
compared to the HCD group (Figure 6). LDLR expression level
was significantly increased in the HCD-KID7 and in the HCD-
L.ac group. Meanwhile, no significant difference was observed in
HMGCR expression in the HCD-KID7 compared to HCD group
(Figure 6). A significant increase in CYP7A1 mRNA expression
level was observed in the HCD-KID7 but not in HCD-L.ac
group compared to HCD. APOE mRNA expression level was
significantly increased in the HCD-KID7 and HCD-L.ac groups
vs. that of the HCD group (Figure 6).
Technological Characteristic of KID7
Viability of KID7 under freeze-drying and storage
conditions
The viability of strain KID7 after freeze-drying condition in
the presence of various food grade additives was given in
Figure 7A. Among the tested additives, 0.5% skim milk +
0.5% galactomannan (SMG), protected the bacterial cells during
freeze-drying condition and the viability was retained at 99.79%,
which was better than in the presence of 1% skim milk alone
(viability = 99.6%) (Figure 7A). Further, we tested KID7 cells in
SMG combination for storage at different temperature conditions
in freeze-dried form for up to 6 months. The viability of KID7
cells in SMG combination was high at 4◦C followed by −20◦C
and 25◦C (Figure 7B). After 6 months of storage, KID7 cells in
SMG matrix retained >90% viability at 4◦C and =89% viability
at −20◦C, which resulted in 1-log-order decrease in viable cells
(Figure 7B) whereas at 25◦C the viability was reduced to 68%
with 2-log-order decrease in the viable cells (Figure 7B). These
results suggest that KID7 combined with SMG matrix could be
stored long term at 4◦C in freeze-dried form and demonstrate
the technological properties of the strain.
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FIGURE 3 | In vitro cholesterol-lowering activity of P. pentosaceus
KID7. (A) Thin-layer chromatography analysis of free cholic acid present in
the culture filtrate of KID7 grown in MRS containing various conjugated bile
salts. 1, MRS+5mM TDCA; 2, MRS+5mM TCA; 3, MRS+5mM GCA; S,
Standard mixture of TDCA, TCA, GCA, cholic acid (CA), and deoxycholic acid
(DCA). (B) Cholesterol reduction activity of strain KID7 and P. pentosaceus
KACC 12311 with or without bile-oxgall. (C) Growth of KID7 and P.
pentosaceus KACC 12311 in MRS-CHO medium with or without bile-oxgall
represented in log cfu/ml. The data are representation of mean values of
three independent assays and error bars indicates ± standard deviation.
TABLE 4 | Effects of KID7 and L. acidophilus on body weight, food intake, and tissues weight in mice.
Parameters Dietary groups
NCD HCD HCD + KID7 HCD + L. acidophilus
BODY WEIGHT (g)
Initial 21.77± 0.48 22.24±0.49 20.89± 0.52 21.03± 0.37
Final 23.24± 0.49 22.01±0.36 21.97± 0.50 22.64± 0.45
Gain 1.88± 0.35 1.56±0.39 1.68± 0.40 1.8± 0.70
Food intake rate (g/mouse/day) 3.24± 0.18 2.50±0.23 2.5± 0.21 2.42± 0.17
TISSUES WEIGHT (g)
Liver 0.9± 0.03*** 1.29±0.05 1.27± 0.04 1.21± 0.52
Epididymal fat 0.16± 0.03 0.16±0.019 0.17± 0.015 0.20± 0.033
NCD, Normal diet; HCD, high-cholesterol diet; KID7, P. pentosaceus KID7; L.ac, L. acidophilus. Data are expressed as means ± SEM (n = 8/group). *** Significantly different at P <
0.005 vs. the HCD group.
Discussion
P. pentosaceus has been approved as an animal feed additive in
the United States, European Union, China, Thailand, Australia,
and New Zealand (Lim and Tan, 2009). In recent years it has
received increased attention and has been characterized for its
possible utilization as probiotic in humans (Osmanagaoglu et al.,
2012; Zhao et al., 2012; Borges et al., 2013; Vidhyasagar and
Jeevaratnam, 2013; Borges and Teixeira, 2014; Garcia-Ruiz et al.,
2014; Lee et al., 2014).
Microbes used as probiotics should satisfy certain safety
criteria such as being negative for mucin degradation activity
(Abe et al., 2010), since microbes degrading mucin can
translocate from the intestinal lumen to other body parts and
cause bacteremia (Abe et al., 2010). Generally, members of LAB
does not possess hemolytic activity. However, Enterococcus and
Bacillus strains possess hemolytic potential and such strains
should be adequately tested and confirmed for non-hemolytic
activity (FAO-WHO, 2002). Testing for bioamine production
is an important safety test, since most of the LAB have the
ability to produce bioamines (Bover-Cid and Holzapfel, 1999).
These are toxic substances generated from the decarboxylation of
amino acids present in foods, themost important being diamines,
which are precursors of carcinogenic nitrosamines (Bover-Cid
and Holzapfel, 1999). Bover-Cid and Holzapfel (1999) observed
that pediococci do not show any ability to produce bioamines,
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FIGURE 4 | Effects of KID7 and L. acidophilus on the serum
biochemical parameters. Mice were fed either normal diet, atherogenic
diet, or atherogenic diet supplemented with KID7 or L. acidophilus for 32
days. (A) T- CHO; (B) LDL-CHO; (C) HDL-CHO; (D) TG; (E) GPT; (F) GOT.
NCD: normal diet; HCD: high-cholesterol diet; HCD-KID7: HCD + P.
pentosaceus KID7; HCD-L.ac: HCD + L. acidophilus. Data are expressed as
means ± SEM (n = 8/group). *, *** indicate significantly lower at P < 0.05
and P < 0.005, respectively, vs. the HCD group.
FIGURE 5 | Effects of P. pentosaceus KID7 and L. acidophilus on
hepatic and fecal lipid levels. Mice were fed either normal diet,
atherogenic diet or atherogenic diet supplemented with KID7 or L.
acidophilus for 32 days. (A) Liver T-CHO; (B) Liver TG; (C) Fecal
T-CHO, and (D) Fecal cholic acid contents. NCD: normal diet; HCD:
high-cholesterol diet; HCD-KID7: HCD + P. pentosaceus KID7;
HCD-L.ac: HCD + L. acidophilus. Data are expressed as means ±
SEM (n = 8/group). *, *** indicate significantly different (lower for A and
B, higher for C and D) at P < 0.05 and P < 0.005, respectively, vs. the
HCD group.
which is in accordance with our observation that KID7 did
not produce bioamine on any of the amino acids tested in
this study (Figure S2). Antibiotic susceptibility is another key
requirement of a probiotic strain used for human or animal
consumption (FAO-WHO, 2002; EFSA, 2012). Ingestion of
probiotic bacteria with transmissible (plasmid or transposon-
borne) antibiotic-resistant genes may lead to generation of new
antibiotic-resistant pathogens in the host gut by horizontal gene
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FIGURE 6 | Effects of KID7 and L. acidophilus on expression
levels of lipid metabolism-related genes in mice liver. The
mRNA expression levels were evaluated by quantitative real-time
PCR. Data were normalized to β-actin RNA expression levels and
then compared to the HCD group, which was assigned a value of
1.0. NCD: normal diet; HCD: high-cholesterol diet; HCD-KID7: HCD
+ P. pentosaceus KID7; HCD-L.ac: HCD + L. acidophilus. Data
are expressed as means ± SEM (n = 8/group). *, *** indicate
significantly higher at P < 0.05 and P < 0.005, respectively, vs. the
HCD group.
transfer (EFSA, 2012). However, ingestion of probiotic bacteria
containing non-transmissible drug resistance genes pose a low
potential for horizontal transfer and generally may be used as
feed-additive (EFSA, 2012). The strain KID7 was resistant to
kanamycin and streptomycin. Pediococcus pentosaceus strains
were shown to have MICs of 256 to >256 and up to 192µg/ml
for kanamycin and streptomycin, respectively (Danielsen et al.,
2007), which are higher than the EFSA recommended cut-off
values. Strains showing higher MIC than the EFSA cut-off values
are considered resistant and must be studied for the genetic basis
of resistance and must be of non-transmissible nature; otherwise,
those strains should not be used as feed additives (EFSA,
2012). The aminoglycoside resistance gene aac(6′)Ie-aph(2′′)Ia
has been reported in some Pediococcus species (Ammor
et al., 2007), which codes for the bifunctional aminoglycoside-
modifying enzyme 69-N-aminoglycoside acetyltransferase-20-
O-aminoglycoside phosphotransferase (Tenorio et al., 2001).
The aac(6′)Ie-aph(2′′)Ia gene confers high level of resistance
to gentamicin in addition to other aminoglycoside antibiotics
(Tenorio et al., 2001), however, KID7 was susceptible to
gentamicin. The genetic basis of streptomycin and kanamycin
resistance in strain KID7 is not known and needs further
study to assess the nature of resistance to these aminoglycoside
antibiotics.
Several previous reports on P. pentosaceus studied the acid
and bile tolerance separately (Jonganurakkun et al., 2008;
Osmanagaoglu et al., 2010; Vidhyasagar and Jeevaratnam, 2013;
Garcia-Ruiz et al., 2014; Lee et al., 2014); however, in real
situations, the consumed probiotic should pass through the
physiological events of ingestion and digestion of the human
gastrointestinal tract (GIT), which include passage through
the oral cavity, stomach and the small intestine (Bove et al.,
2012). Tolerance to the GIT is one of the selection criterion
recommended by FAO-WHO (2002); hence, we studied the
tolerance of KID7 to progressive oral, gastric, and intestinal
stress (OGT assay) in order to mimic the physiological condition.
Tolerance of L. plantarum strains to oral and gastric stress up
to pH 3 was reported previously (Bove et al., 2012). However,
when the pH reduced from 3 to 2 a drastic drop of viability
was observed for all L. plantarum strains and L. acidophilus LA5
(Bove et al., 2012) and at the end of the OGT assay a tendency
to recover viability was noticed for bacterial samples (Bove et al.,
2012). In our study, we observed KID7 strain was able to recover
from cell damage caused by the OGT transit (Figure 1), which is
in accordance with Bove et al. (2012). Survival and tolerance of
the strains are essential to express the probiotic functions in the
intestine (Kumar et al., 2011).
Adherence and colonization of LAB strains in the intestine
can be studied using human intestinal epithelial cell models
such as Caco-2 and HT-29 cell lines, in vitro (Tuo et al., 2013).
KID7 showed higher adherence to Caco-2 cells as compared
to L. rhamnosus GG and L. acidophilus ATCC 43121. A good
adherence capacity can promote gut residence time of a probiotic
bacteria, aids in pathogen exclusion and interaction with host
cells for the protection of epithelial cells and immunemodulation
(Lebeer et al., 2008). Several previous reports demonstrated that
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FIGURE 7 | Viability of strains KID7 under freeze-drying and storage
conditions. (A) Viability of strain KID7 after freeze-drying with various
combinations of food grade additives such as SM, skim milk (1%); G,
galactomannan (1%); WBH, wheat bran hydrolysate (1%); SMG, skim milk
(0.5%) + galactomannan (0.5%); WBHG, wheat bran hydrolysate (0.5%) +
galactomannan (0.5%); and Control, KID7 cells in PBS without food grade
additives. (B) Viability of strain KID7 combined with SMG, skim milk (0.5 %) +
galactomannan (0.5%) under different storage conditions such as −20◦C ( ,
), 4◦C ( , N), and 25◦C ( , •), up to 6 months. Histogram represents
percentage viability of KID7 under different storage condition. Line graph
represents relative logarithmic value of colony-forming units of KID7 under
different storage condition. Error bars represent standard error of mean of
three independent experiments. *P < 0.05 and ***P < 0.005 significantly
different at the P-values compared to initial count.
P. pentosaceus strains adhered to intestinal epithelial cells better
than Lactobacillus strains (Turpin et al., 2012; Thirabunyanon
and Hongwittayakorn, 2013; Garcia-Ruiz et al., 2014).
Antimicrobial activity of LAB against pathogens can be due to
the production of organic acids, hydrogen peroxide (H2O2), and
bacteriocins (Vesterlund, 2009). KID7 does not produce H2O2
(Figure S5). The antimicrobial activity of culture filtrate from
KID7 against gram-positive and -negative pathogenic bacteria
and not against LAB strains suggest that the antimicrobial activity
could be due to the production of organic acids.
BSH enzymes deconjugate the conjugated bile acids into the
amino acids (glycine or taurine) and free bile acids (cholic acid
or deoxycholic acid) (Joyce et al., 2014). It has been reported that
high-level expression of BSH activity by gut microbiota resulted
in host weight reduction and cholesterol reduction (Joyce et al.,
2014). Hence, BSH activity is an important selection criterion
for probiotic microbes to be used for cholesterol reduction.
Furthermore, BSH activity is also among the selection criteria
recommended by FAO-WHO (2002) for screening potential
probiotic strains. Bile acids are synthesized in the liver using
cholesterol as precursor. BSH activity of probiotics in the gut
could modify the conjugated bile acids and excretion of the
free bile acids, which results in de novo synthesis of conjugated
bile acids from cholesterol to maintain hepatic bile acid pool
(Herrema et al., 2010; Degirolamo et al., 2014). Thus, bacterial
BSH activity in the gut acts as a sink for cholesterol (Joyce et al.,
2014).
Several LAB strains have been reported to possess
in vitro cholesterol assimilation/uptake activity. LAB exhibit
mechanisms, such as cholesterol adsorption to cell wall, and
cholesterol assimilation into cell membrane (Liong and Shah,
2005a) and co-precipitation with deconjugated bile acids (Liong
and Shah, 2005b) in in vitro assays. Cholesterol removal from
culture medium by KID7 could involve any of these mechanisms.
Previous reports on cholesterol reduction by Pediococcus strains
showed varying levels (58–73%) of cholesterol reduction in
liquid medium supplied with 100–200µg/ml of cholesterol in
the presence of 0.3% bile (Vidhyasagar and Jeevaratnam, 2013).
In the present study, we observed a reduction in cholesterol-
lowering activity in the presence of 0.3 and 0.5% bile oxgall,
dose-dependently (Figure 3B). This reduction in the cholesterol
assimilation activity is due to reduction in cell growth of KID7
in 0.3 and 0.5% bile oxgall (Figure 3C). The reduction in cell
growth in the presence of oxgall was also reported for a L.
fermentum strain (Pereira et al., 2003), however, the cholesterol
assimilation activity increased despite low growth rate. In our
case, lower growth led to lower cholesterol assimilation by KID7
cells. Although, KID7 tolerated bile during brief exposure of
2 h and showed good viability in the OGT assay, growth of
the strain was significantly affected during longer exposure
to bile as is the case with cholesterol-lowering activity in the
presence of bile. The type strain P. pentosaceus KACC 12311
also followed the same pattern as KID7; however, it showed
relatively lower growth and cholesterol assimilation activity in
the presence and absence of bile oxgall. The lower growth of the
KID7 and P. pentosaceus KACC 12311 in bile-supplied medium
could be due to bile salt-deconjugating activity of the strains,
which leads to accumulation of free bile acids that are more
toxic than conjugated bile (Pereira et al., 2003). However, these
in vitro assays do not reflect the true nature of probiotic strains
in cholesterol-lowering activity, since the conditions in vivo are
completely different. Hence, the probiotic activity of any strain
must be validated through in vivo studies.
We tested the strain KID7 in vivo to confirm the
cholesterol-lowering activity in atherogenic diet-induced
hypercholesterolemic mice in comparison with the previously
reported cholesterol-lowering probiotic strain L. acidophilus
ATCC 43121 as positive control. Supplementation of
hypercholesterolemic mice with strain KID7 significantly
lowered the serum total cholesterol level, LDL level and hepatic
total cholesterol level. Reduction in the serum LDL level and
cholesterol level correlated with our observation of increased
expression of genes related to cholesterol metabolism in liver
such as LDLR and ApoE (Figure 6). Increased expression of
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LDL-receptor will lead to increased absorption of LDL by
hepatocytes. The absorbed LDL is degraded and the cholesterol
is added to the cholesterol pool (Cohen, 2008). An increase
in cholesterol pool will down regulate HMG CoA-reductase
(HMGCR) and LDL receptor (LDLR) expression. In our study,
we did not observe any significant down regulation in HMGCR
expression in the HCD-KID7 group compared to HCD group,
whereas LDLR expression and APOE expression increased in
the HCD-KID7 group. This could be due to sinking cholesterol
level in cholesterol pool due to expression of CYP7A1 (Figure 6),
which codes for the enzyme cholesterol 7-α-hydroxylase, which
catalyzes a rate-limiting step in the de novo synthesis of bile
acids from cholesterol (Cohen, 2008). Bile salts are secreted into
bile duct at a rate of ∼24 g/day, but their synthesis is only a
fraction of that rate, because most of the bile salts are recycled
to the liver from the ileum (Cohen, 2008). Reduction in bile salt
reabsorption due to bile salt hydrolase activity in the gut will
cause bile synthesis from cholesterol to maintain the bile salts
pool size. The increased expression of CYP7A1 and a decrease
in hepatic cholesterol pool also correlated with an increase in
total cholic acid excretion in feces of the HCD-KID7 group
(Figure 5D). These results suggests that cholesterol-lowering
activity of KID7 in vivo could be due to its bile salt hydrolase
activity. We also observed a significant increase in the level of
hepatic LDL mRNA expression in the HCD-L.ac group, which is
consistent with Park et al. (2007). In addition to the LDLR gene,
we observed the expression of SREBF2, and APOE genes in the
HCD-L.ac group, which was not previously reported in studies
using L. acidophilus ATCC 43121.
A previous study (Moon et al., 2014) on lipid-lowering effect
of Pediococcus acidilactici strain M76 and P. acidilactici DSM
20284 reported a reduction in serum cholesterol level of 12 and
2.4%, respectively, and a reduction in total hepatic cholesterol
level of 30.5 and 14.9%, respectively for the two P. acidilactici
strains used in their study. Compared to those results, KID7
showed a 19.8% reduction in serum total cholesterol level,
a 35.5% reduction in LDL cholesterol level, and a reduction
in liver total cholesterol level of 19.7%. Our results indicated
that KID7 could be used as a potential cholesterol-lowering
probiotic that needs to be confirmed by clinical trials in
humans.
Probiotic supplements are usually in the form of dry powders
to reduce water activity and protect viability. The preferred
drying method is freeze-drying as it preserves viability of the
probiotic bacteria. However, not all strains tolerate drying and
may show significant loss of viability (Ross et al., 2005). Hence,
protective agents and stabilizing agents are added while freeze-
drying (Ross et al., 2005). The combination of skim milk and
galactomannan increased the viability of KID7 after freeze-drying
and subsequent storage conditions. It was reported that skim
milk acts as a cryoprotectant and prevents the cells from the
damage during freeze-drying (Ross et al., 2005). Additionally,
galactomannan from locust bean is a natural polysaccharide used
as emulsifying, thickening, and stabilizing agent in the food
industry (Cheow et al., 2014). It has been reported elsewhere
that spray-drying of probiotic Lactobacillus paracasei NFBC in
a milk medium supplemented with gum acacia provided better
protection to the cells than milk powder alone (Desmond et al.,
2002).
In conclusion, the P. pentosaceus KID7 reported in this study
exhibited cholesterol-lowering activity in vivo and possessed
the essential characteristics to become a potential probiotic.
Furthermore, KID7 maintained good viability during freeze-
drying and storage when formulated with a combination of
skim milk and galactomannan, which can be utilized in the
large-scale production of P. pentosaceus KID7-based probiotic
products after validation of the probiotic ability in human clinical
trials.
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